We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Conagra Brands
CAG
$7.07B
| $11.6M | 0.08% |
316,592
+175,806
| +125% | +$6.31M |
|
252
AMC Global Media
AMCX
$430M
| $11.6M | 0.08% |
223,789
+163,408
| +271% | +$8.95M |
|
253
PACCAR
PCAR
$69.6B
| $11.5M | 0.08% |
+292,422
| New | +$11.1M |
|
|
AAWW
254
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $11.4M | 0.08% |
266,938
+153,029
| +134% | +$5.98M |
|
|
TSRO
255
DELISTED
TESARO, Inc.
TSRO
| $11.4M | 0.08% |
113,862
-37,013
| -25% | -$3.46M |
|
256
Alphabet (Google) Class C
GOOG
$3.9T
| $11.4M | 0.08% |
292,520
+125,420
| +75% | +$4.76M |
|
|
YHOO
257
DELISTED
Yahoo Inc
YHOO
| $11.4M | 0.08% |
263,383
+106,575
| +68% | +$4.37M |
|
|
TECD
258
DELISTED
Tech Data Corp
TECD
| $11.3M | 0.08% |
+133,745
| New | +$10.4M |
|
259
Travel + Leisure Co
TNL
$4.54B
| $11.3M | 0.08% |
+371,351
| New | +$11.9M |
|
260
MBIA
MBI
$288M
| $11.2M | 0.08% |
1,443,077
+261,455
| +22% | +$2.06M |
|
261
SBA Communications
SBAC
$18.4B
| $11.2M | 0.08% |
100,222
+83,923
| +515% | +$9.49M |
|
|
BERY
262
DELISTED
Berry Global Group, Inc.
BERY
| $11M | 0.08% |
273,184
+32,029
| +13% | +$1.26M |
|
|
SAAS
263
DELISTED
inContact, Inc.
SAAS
| $11M | 0.08% |
786,318
+762,318
| +3,176% | +$10.6M |
|
|
FLTX
264
DELISTED
Fleetmatics Group PLC
FLTX
| $10.9M | 0.08% |
+182,056
| New | +$9.96M |
|
265
Pentair
PNR
$10.2B
| $10.9M | 0.08% |
252,324
+201,300
| +395% | +$8.48M |
|
266
Akamai
AKAM
$16.8B
| $10.9M | 0.08% |
205,051
+48,602
| +31% | +$2.6M |
|
267
Exelixis
EXEL
$13.9B
| $10.8M | 0.08% |
847,156
+738,237
| +678% | +$7.98M |
|
|
CTB
268
DELISTED
Cooper Tire & Rubber Co.
CTB
| $10.8M | 0.08% |
+284,565
| New | +$9.52M |
|
|
XIFR
269
XPLR Infrastructure LP
XIFR
$1.18B
| $10.8M | 0.08% |
384,562
+180,859
| +89% | +$5.45M |
|
270
Repligen
RGEN
$7.44B
| $10.7M | 0.08% |
355,898
+283,746
| +393% | +$8.56M |
|
271
Teva Pharmaceuticals
TEVA
$35.9B
| $10.6M | 0.08% |
+231,251
| New | +$12.1M |
|
272
Neurocrine Biosciences
NBIX
$17.7B
| $10.6M | 0.08% |
209,689
-21,436
| -9% | -$1.07M |
|
|
BLD
273
DELISTED
TopBuild
BLD
| $10.6M | 0.08% |
318,355
-8,602
| -3% | -$303K |
|
274
Casey's General Stores
CASY
$31.9B
| $10.5M | 0.07% |
87,284
+82,114
| +1,588% | +$10.6M |
|
275
KBR
KBR
$4.68B
| $10.4M | 0.07% |
+687,105
| New | +$10.1M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.